EP Patent

EP3856169A1 — Methods of treating myeloproliferative disorders

Assigned to Impact Biomedicines Inc · Expires 2021-08-04 · 5y expired

What this patent protects

The present disclosure provides methods of mitigating thiamine deficiency.

USPTO Abstract

The present disclosure provides methods of mitigating thiamine deficiency.

Drugs covered by this patent

Patent Metadata

Patent number
EP3856169A1
Jurisdiction
EP
Classification
—
Expires
2021-08-04
Drug substance claim
No
Drug product claim
No
Assignee
Impact Biomedicines Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.